Occurrence of ESBLs in Clinical Isolates of Klebsiella Species and Comparative Analysis of Phenotypic Detection Methods

Author(s): Taqdees Malik*, Asma Naim

Journal Name: Anti-Infective Agents
Formerly Anti-Infective Agents in Medicinal Chemistry

Volume 18 , Issue 3 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Aims: Drug resistance enzymes like beta-lactamases and Extended-Spectrum Beta- Lactamases (ESBLs) are mostly produced in the response of mutation and a few other factors. These enzymes are plasmid-mediated that can confer resistance against several β-lactam agents including cephalosporin and extended-spectrum cephalosporin. This study is conducted to determine the frequency of ESBL producing Klebsiella strains and to compare the phenotypic detection methods among various clinical samples collected from a commercial centralized Microbiology diagnostic laboratory.

Materials and Methods: 125 Klebsiella strains were collected for this study. After identification and susceptibility testing, the phenotypic characterization of ESBL producing K. pneumoniae (n=89) and K. oxytoca (n=36) species was performed by using the double disc synergy test and the combination disc test.

Results: In our study, 80 (64%) Klebsiella isolates were found to be ESBL positive due to their ability to produce an extended zone of inhibition with combination disc whereas 45 (36%) isolates were ESBL negative with no extended zone of inhibition. The phenotypic findings obtained by using the combination disc method and double disc synergy method were re-confirmed by molecular methods. By comparing the phenotypic finding with the genotypic results, we identified 80 (64%) Klebsiella isolates as ESBL positive and 45 (36%) isolates as ESBL negative. These genotypic findings of the ESBL producing strains were similar to the results obtained from the combination disc method. It also confirmed that the double disc synergy test was unable to detect 47 ESBL producing klebsiella strains.

Conclusion: For implementing strict infection control policy and to stop the spread of resistant strains, it is important to detect ESBL producing isolates more rapidly. A suitable antimicrobial therapy can be started timely with the early detection of resistance enzymes either phenotypically or genotypically. It has been proved that the combination disc test can be used more reliably and preferably as compared to the double disc synergy test for the detection of ESBL enzymes produced by Klebsiella strains.

Keywords: Klebsiella spp, anti-bacterial agents, drug resistance, urinary tract infections, plasmids, ESBL.

[1]
Quansah, E.; Amoah Barnie, P.; Omane Acheampong, D.; Obiri-Yeboah, D.; Odarkor Mills, R.; Asmah, E.; Cudjoe, O.; Dadzie, I. Geographical Distribution of β-lactam resistANCE among Klebsiella spp. from selected health facilities in ghana. Trop Med Infect Dis, 2019, 4(3) E117
[http://dx.doi.org/10.3390/tropicalmed4030117] [PMID: 31484298]
[2]
Podschun, R.; Ullmann, U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev., 1998, 11(4), 589-603.
[http://dx.doi.org/10.1128/CMR.11.4.589] [PMID: 9767057]
[3]
Hyun, M.; Lee, J.Y.; Kim, H.A.; Ryu, S.Y. comparison of Escherichia Coli and Klebsiella Pneumoniae acute pyelonephritis in Korean patients. Infect. Chemother., 2019, 51(2), 130-141.
[http://dx.doi.org/10.3947/ic.2019.51.2.130] [PMID: 31270992]
[4]
Haque, M.; Sartelli, M.; McKimm, J.; Abu Bakar, M. Health care-associated infections - an overview. Infect. Drug Resist., 2018, 11, 2321-2333.
[http://dx.doi.org/10.2147/IDR.S177247] [PMID: 30532565]
[5]
Gashe, F.; Mulisa, E.; Mekonnen, M.; Zeleke, G. Antimicrobial resistance profile of different clinical isolates against third-generation cephalosporins. J. Pharm. (Cairo), 2018, •••20185070742
[http://dx.doi.org/10.1155/2018/5070742] [PMID: 30271652]
[6]
Aslam, B.; Wang, W.; Arshad, M.I.; Khurshid, M.; Muzammil, S.; Rasool, M.H.; Nisar, M.A.; Alvi, R.F.; Aslam, M.A.; Qamar, M.U.; Salamat, M.K.F.; Baloch, Z. Antibiotic resistance: a rundown of a global crisis. Infect. Drug Resist., 2018, 11, 1645-1658.
[http://dx.doi.org/10.2147/IDR.S173867] [PMID: 30349322]
[7]
Ayukekbong, J.A.; Ntemgwa, M.; Atabe, A.N. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob. Resist. Infect. Control, 2017, 6, 47.
[http://dx.doi.org/10.1186/s13756-017-0208-x] [PMID: 28515903]
[8]
Rajivgandhi, G.; Maruthupandy, M.; Ramachandran, G.; Priyanga, M.; Manoharan, N. Detection of ESBL genes from ciprofloxacin re-sistant Gram negative bacteria isolated from urinary tract infections (UTIs). Front. Lab. Med., 2018, 2(3), 5-13.
[http://dx.doi.org/10.1016/j.flm.2018.01.001]
[9]
Pachori, P.; Gothalwal, R.; Gandhi, P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis., 2019, 6(2), 109-119.
[http://dx.doi.org/10.1016/j.gendis.2019.04.001] [PMID: 31194018]
[10]
Shaikh, S.; Fatima, J.; Shakil, S.; Rizvi, S.M.D.; Kamal, M.A. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J. Biol. Sci., 2015, 22(1), 90-101.
[http://dx.doi.org/10.1016/j.sjbs.2014.08.002] [PMID: 25561890]
[11]
Munita, J.M.; Arias, C.A. Mechanisms of Antibiotic Resistance. Microbiol. Spectr, 2016, 4(2)10.1128
[http://dx.doi.org/10.1128/9781555819286.ch17]
[12]
Rawat, D.; Nair, D. Extended-spectrum β-lactamases in Gram Negative Bacteria. J. Glob. Infect. Dis., 2010, 2(3), 263-274.
[http://dx.doi.org/10.4103/0974-777X.68531] [PMID: 20927289]
[13]
Everaert, A.; Coenye, T. Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species. Antimicrob. Resist. Infect. Control, 2016, 5, 44.
[http://dx.doi.org/10.1186/s13756-016-0142-3] [PMID: 27895902]
[14]
Dasgupta, A.; Majumdar, T.; Bhowmik, R. Identification and molecular characterization of ESBL producing uropathogenic Escherichia coli strain isolated from a tertiary care hospital of Tripura. J. Evolution Med. Dent. Sci., 2018, 7(24), 2829-2833.
[http://dx.doi.org/10.14260/jemds/2018/638]
[15]
Abayneh, M.; Tesfaw, G.; Abdissa, A. Isolation of extended-spectrum β-lactamase- (ESBL-) producing Escherichia coli and Klebsiella pneumoniae from patients with community-onset urinary tract infections in Jimma university specialized hospital, southwest Ethiopia. Can. J. Infect. Dis. Med. Microbiol., 2018, 2018(13)4846159
[http://dx.doi.org/10.1155/2018/4846159] [PMID: 30651898]
[16]
Ibrahim, M.E.; Abbas, M.; Al-Shahrai, A.M.; Elamin, B.K. Phenotypic Characterization and antibiotic resistance patterns of Extended- Spectrum β-Lactamase- and AmpC β-Lactamase-producing gram-negative bacteria in a referral hospital, Saudi Arabia Can. J. Infect. Dis. Med., 2019.Article ID 6054694.
[17]
Kazemian, H.; Heidari, H.; Ghanavati, R.; Ghafourian, S.; Yazdani, F.; Sadeghifard, N.; Valadbeigi, H.; Maleki, A.; Pakzad, I. Phenotypic and genotypic characterization of ESBL-, AMPC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates. Med. Princ. Pract., 2019, 28(6), 547-551.
[http://dx.doi.org/10.1159/000500311] [PMID: 30995662]
[18]
Li, B.; Webster, T.J. Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. J. Orthop. Res., 2018, 36(1), 22-32.
[PMID: 28722231]
[19]
Mohammed, I.; Abass, E. Phenotypic detection of Extended Spectrum β-Lactamases (ESBL) among gram negative uropathogens reveals highly susceptibility to imipenem. Pak. J. Med. Sci., 2019, 35(4), 1104-1109.
[http://dx.doi.org/10.12669/pjms.35.4.207] [PMID: 31372151]
[20]
Sahni, R.D.; Mathai, D.; Sudarsanam, T.D.; Balaji, V.; Brahamadathan, K.N.; Jesudasan, M.V.; Lalitha, M.K. Balaji. Extended-spectrum beta-lactamase producers: detection for the diagnostic laboratory. J. Glob. Infect. Dis., 2018, 10(3), 140-146.
[http://dx.doi.org/10.4103/jgid.jgid_49_17] [PMID: 30166813]
[21]
Antony, S.; Ravichandran, K.; Kanungo, R. Multidrug-resistant Enterobacteriaceae colonising the gut of adult rural population in South India. Indian J. Med. Microbiol., 2018, 36(4), 488-493.
[http://dx.doi.org/10.4103/ijmm.IJMM_18_388] [PMID: 30880694]
[22]
Andrew, B.; Kagirita, A.; Bazira, J. Prevalence of extended-spectrum beta-lactamases-producing microorganisms in patients admitted at KRRH, southwestern Uganda. Int. J. Microbiol., 2017, •••20173183076
[http://dx.doi.org/10.1155/2017/3183076] [PMID: 28270849]
[23]
Bajpai, V.; Govindaswamy, A.; Khurana, S.; Batra, P.; Aravinda, A.; Katoch, O.; Hasan, F.; Malhotra, R.; Mathur, P. Phenotypic & genotypic profile of antimicrobial resistance in Pseudomonas species in hospitalized patients. Indian J. Med. Res., 2019, 149(2), 216-221.
[http://dx.doi.org/10.4103/ijmr.IJMR_1_18] [PMID: 31219086]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 3
Year: 2020
Published on: 11 September, 2020
Page: [255 - 260]
Pages: 6
DOI: 10.2174/2211352517666191114130036
Price: $25

Article Metrics

PDF: 15
HTML: 1